Detalhe da pesquisa
1.
Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study.
J Am Acad Dermatol
; 89(1): 36-44, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870370
2.
Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis Flares.
Dermatology
; 239(3): 345-354, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796336
3.
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
N Engl J Med
; 381(18): 1718-1727, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566307
4.
Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.
N Engl J Med
; 379(18): 1722-1731, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30220235
5.
Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial.
Eur Respir J
; 58(1)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33419890
6.
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities.
Respir Res
; 22(1): 125, 2021 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33902584
7.
Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme.
Respir Res
; 21(1): 7, 2020 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31906942
8.
Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis.
Respir Res
; 21(1): 312, 2020 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33239000
9.
Long-term treatment with nintedanib in Asian patients with idiopathic pulmonary fibrosis: Results from INPULSIS®-ON.
Respirology
; 25(4): 410-416, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31329360
10.
Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis and Right Heart Dysfunction. A Prespecified Subgroup Analysis of a Double-Blind Randomized Clinical Trial (INSTAGE).
Am J Respir Crit Care Med
; 200(12): 1505-1512, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31365829
11.
Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis.
BMC Pulm Med
; 20(1): 3, 2020 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914963
12.
Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial.
Am J Respir Crit Care Med
; 197(3): 356-363, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28889759
13.
Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension.
Thorax
; 73(6): 581-583, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28993537
14.
Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis.
Respir Res
; 16: 116, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26400368
15.
Reply to Rajchgot et al.: Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med
; 198(8): 1105-1106, 2018 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30025211
16.
Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil™ 1 study.
J Dermatol
; 50(2): 183-194, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282833
17.
Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score.
Arthritis Rheumatol
; 74(3): 518-526, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34514739
18.
Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial.
Arthritis Rheumatol
; 74(6): 1039-1047, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35199968
19.
Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
Adv Ther
; 37(7): 3292-3298, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32451950
20.
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Lancet Respir Med
; 8(5): 453-460, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32145830